ticlopidine has been researched along with Osteoarthritis in 1 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
Osteoarthritis: A progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans.
Excerpt | Relevance | Reference |
---|---|---|
"The objective of this clinical study is to evaluate possible interactions between antiplatelet agents, anticoagulants, thyroid hormone replacement therapy and a formulation of curcumin (Meriva®) that resulted effective for the complementary treatment of osteoarthritis." | 3.88 | Interaction study between antiplatelet agents, anticoagulants, thyroid replacement therapy and a bioavailable formulation of curcumin (Meriva®). ( Belcaro, G; Cotellese, R; Dugall, M; Eggenhoffner, R; Giacomelli, L; Hosoi, M; Hu, S; Ledda, A; Peterzan, P; Riva, A; Togni, S, 2018) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hu, S | 1 |
Belcaro, G | 1 |
Dugall, M | 1 |
Peterzan, P | 1 |
Hosoi, M | 1 |
Ledda, A | 1 |
Riva, A | 1 |
Giacomelli, L | 1 |
Togni, S | 1 |
Eggenhoffner, R | 1 |
Cotellese, R | 1 |
1 other study available for ticlopidine and Osteoarthritis
Article | Year |
---|---|
Interaction study between antiplatelet agents, anticoagulants, thyroid replacement therapy and a bioavailable formulation of curcumin (Meriva®).
Topics: Anticoagulants; Aspirin; Blood Glucose; Clopidogrel; Curcumin; Drug Compounding; Drug Interactions; | 2018 |